Skip to content

Evaluating the Impact of Including Virtual Dietary Education Within an Electronic Irritable Bowel Syndrome Pathway

IBS - Irritable Bowel Syndrome

Irritable bowel syndrome is a functional bowel disorder that affects many Canadians. The syndrome involves abdominal pain and change in frequency or form of bowel movements, and these symptoms can lead to a decreased quality of life for patients. Primary care physicians are dissatisfied with current referral processes, and patients may wait a long time to receive the correct diagnosis. Diet is known to exacerbate symptoms of IBS. In Canada, accessing dietary treatment for IBS is a challenge due to lack of resources. Some patients lack access to dietary interventions, and others are given advice that is not evidenced based. Use of eHealth technology, such as virtual education delivered by a dietician, may allow for more widespread access to dietary interventions for IBS. Virtual education can include one on one dietary education, online group-based education, and the use of apps. Currently, there is a gap in knowledge whether dietary intervention for IBS, delivered virtually by a dietician, is effective in treating IBS.

null

Participation Requirements

  • Sex:

    ALL

  • Eligible Ages:

    18 to 65

Participation Criteria

Inclusion Criteria:

* Recurrent abdominal pain on average at least 1 day/ week in the last 3 months associated with two or more of the following criteria: related to defecation, or association with a change in frequency of stool or associated with a change in form (appearance) of stool
* Willingness to change diet
* Access to a device for accessing virtual dietary education

Exclusion Criteria:

* New onset symptoms within past year in age 50 and above
* Rectal bleeding
* Inflammatory Bowel Disease
* Unexplained recent weight loss
* Gastrointestinal surgery with removal of gallbladder or segments of the bowel
* Having an eating disorder

Study Location

QEII Health Sciences Centre
QEII Health Sciences Centre
Halifax, N.S.
Canada

Contact Study Team

Primary Contact

Jennifer L Jones, MD

[email protected]
902-473-1499
Study Sponsored By
Nova Scotia Health Authority
Participants Required
More Information
Study ID: NCT05721742